WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
maximize
Machine translation
1. (WO2017107945) CRYSTALLINE FORM OF BENZOATE OF DIPEPTIDYL PEPTIDASE-IV INHIBITOR
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/107945    International Application No.:    PCT/CN2016/111445
Publication Date: 29.06.2017 International Filing Date: 22.12.2016
IPC:
C07D 471/04 (2006.01), A61K 31/4545 (2006.01), A61P 3/10 (2006.01), A61P 5/50 (2006.01), A61P 3/06 (2006.01)
Applicants: XUANZHU PHARMA CO.,LTD. [CN/CN]; 2518, Tianchen Street, National High-tech Development Zone Jinan, Shandong 250101 (CN)
Inventors: SHU, Chutian; (CN).
WANG, Zhenhua; (CN)
Agent: CCPIT PATENT AND TRADEMARK LAW OFFICE; 8th Floor, Vantone New World Plaza, 2 Fuchengmenwai Street, Xicheng District Beijing 100037 (CN)
Priority Data:
201510990347.X 24.12.2015 CN
Title (EN) CRYSTALLINE FORM OF BENZOATE OF DIPEPTIDYL PEPTIDASE-IV INHIBITOR
(FR) FORME CRISTALLINE DE BENZOATE D'INHIBITEUR DE DIPEPTIDYL PEPTIDASE-IV
(ZH) 二肽基肽酶-IV抑制剂的苯甲酸盐的晶型
Abstract: front page image
(EN)The present invention relates to a crystalline form of benzoate of a dipeptidyl peptidase-IV inhibitor, a method for preparing the same, a pharmaceutical composition, and a use thereof. Specifically, the present invention relates to a crystalline form of benzoate of a compound used as a dipeptidyl peptidase-IV inhibitor and represented by formula (1), namely (R)-2-((7-(3-aminopiperidine-1-yl)-3,5-dimethyl-2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridine-1-yl)methyl)benzonitrile, a method for preparing the same, a pharmaceutical composition, and a use thereof.
(FR)La présente invention concerne une forme cristalline de benzoate d'un inhibiteur de dipeptidyl-peptidase-IV, son procédé de préparation, une composition pharmaceutique, et une utilisation associée. Plus précisément, la présente invention concerne une forme cristalline de benzoate d'un composé utilisé comme inhibiteur de dipeptidyl peptidase-IV et représenté par la formule (1), à savoir le (R)-2-((7-(3-aminopipéridin-1-yl)-3,5-diméthyl-2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridin-1-yl)méthyl)benzonitrile, son procédé de préparation, une composition pharmaceutique et une utilisation associée.
(ZH)本发明涉及二肽基肽酶-IV抑制剂的苯甲酸盐的晶型、其制备方法、药物组合物及应用。具体地涉及作为二肽基肽酶-IV抑制剂的式(1)所示化合物(R)-2-((7-(3-氨基哌啶-1-基)-3,5-二甲基-2-氧代-2,3-二氢-1H-咪唑并(4,5-b)吡啶-1-基)甲基)苯甲腈的苯甲酸盐的晶型、其制备方法、药物组合物和应用。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)